Oncology Institute Files 8-K on Director/Officer Changes
Ticker: TOIIW · Form: 8-K · Filed: May 7, 2025 · CIK: 1799191
| Field | Detail |
|---|---|
| Company | Oncology Institute, Inc. (TOIIW) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, financial-statements
TL;DR
TOI filed an 8-K detailing director/officer changes and financial statements.
AI Summary
Oncology Institute, Inc. (TOI) filed an 8-K on May 7, 2025, reporting events as of May 2, 2025. The filing covers the departure of directors, election of directors, appointment of officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in the leadership and governance structure of Oncology Institute, Inc., which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or events.
Key Players & Entities
- Oncology Institute, Inc. (company) — Filer
- DFP HEALTHCARE ACQUISITIONS CORP. (company) — Former Company Name
- 0001799191 (company) — Central Index Key
FAQ
What specific director or officer positions were affected by the changes reported in the 8-K?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 2, 2025.
What is the SEC file number for this Oncology Institute, Inc. 8-K filing?
The SEC file number for this filing is 001-39248.
What was the former name of Oncology Institute, Inc.?
The former name of Oncology Institute, Inc. was DFP HEALTHCARE ACQUISITIONS CORP.
What other information is included in this 8-K filing besides director and officer changes?
This 8-K filing also includes Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Oncology Institute, Inc. (TOIIW).